Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Editorial: Moving Forward PDF $40.00
$40.00
× Placeholder Delusionality and Response to Open-Label Fluvoxamine in Body Dysmorphic Disorder PDF $40.00
$40.00
× Placeholder Three-Month Follow-up Study of Mental Health Outcomes After a National COVID-19 Lockdown: Comparing Patients With Mood or Anxiety Disorders Living in an Area With a Higher Versus Lower Infection Incidence PDF $40.00
$40.00
× Placeholder Switching From Clozapine to Olanzapine in Treatment-Refractory Schizophrenia: Safety, Clinical Efficacy, and Predictors of Response PDF $40.00
$40.00
× Placeholder Bipolar Symptoms in Adult Attention-Deficit/Hyperactivity Disorder: A Cross-Sectional Study of 510 Clinically Diagnosed Patients and 417 Population-Based Controls PDF $40.00
$40.00
× Placeholder Disulfiram Use in Patients With Abnormal Liver Function Test Results PDF $40.00
$40.00
× Placeholder Nonsteroidal Anti-Inflammatory Drugs in Schizophrenia: Ready for Practice or a Good Start? A Meta-Analysis PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $280.00
Total $280.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe